Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial

Robert J. Lederman, Alan N. Tenaglia, R. David Anderson, James B. Hermiller, Krishna Rocha-Singh, Farrell O. Mendelsohn, William R. Hiatt, Thomas Moon, M. J. Whitehouse, Brian H. Annex

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)192-195
Number of pages4
JournalAmerican Journal of Cardiology
Volume88
Issue number2
DOIs
StatePublished - Jul 15 2001
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Lederman, R. J., Tenaglia, A. N., Anderson, R. D., Hermiller, J. B., Rocha-Singh, K., Mendelsohn, F. O., ... Annex, B. H. (2001). Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial. American Journal of Cardiology, 88(2), 192-195. https://doi.org/10.1016/S0002-9149(01)01622-8

Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial. / Lederman, Robert J.; Tenaglia, Alan N.; Anderson, R. David; Hermiller, James B.; Rocha-Singh, Krishna; Mendelsohn, Farrell O.; Hiatt, William R.; Moon, Thomas; Whitehouse, M. J.; Annex, Brian H.

In: American Journal of Cardiology, Vol. 88, No. 2, 15.07.2001, p. 192-195.

Research output: Contribution to journalArticle

Lederman, RJ, Tenaglia, AN, Anderson, RD, Hermiller, JB, Rocha-Singh, K, Mendelsohn, FO, Hiatt, WR, Moon, T, Whitehouse, MJ & Annex, BH 2001, 'Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial', American Journal of Cardiology, vol. 88, no. 2, pp. 192-195. https://doi.org/10.1016/S0002-9149(01)01622-8
Lederman, Robert J. ; Tenaglia, Alan N. ; Anderson, R. David ; Hermiller, James B. ; Rocha-Singh, Krishna ; Mendelsohn, Farrell O. ; Hiatt, William R. ; Moon, Thomas ; Whitehouse, M. J. ; Annex, Brian H. / Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial. In: American Journal of Cardiology. 2001 ; Vol. 88, No. 2. pp. 192-195.
@article{ce0bc2d849fc4ead965641f900b573a8,
title = "Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial",
author = "Lederman, {Robert J.} and Tenaglia, {Alan N.} and Anderson, {R. David} and Hermiller, {James B.} and Krishna Rocha-Singh and Mendelsohn, {Farrell O.} and Hiatt, {William R.} and Thomas Moon and Whitehouse, {M. J.} and Annex, {Brian H.}",
year = "2001",
month = "7",
day = "15",
doi = "10.1016/S0002-9149(01)01622-8",
language = "English (US)",
volume = "88",
pages = "192--195",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Design of the therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (TRAFFIC) trial

AU - Lederman, Robert J.

AU - Tenaglia, Alan N.

AU - Anderson, R. David

AU - Hermiller, James B.

AU - Rocha-Singh, Krishna

AU - Mendelsohn, Farrell O.

AU - Hiatt, William R.

AU - Moon, Thomas

AU - Whitehouse, M. J.

AU - Annex, Brian H.

PY - 2001/7/15

Y1 - 2001/7/15

UR - http://www.scopus.com/inward/record.url?scp=0035879697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035879697&partnerID=8YFLogxK

U2 - 10.1016/S0002-9149(01)01622-8

DO - 10.1016/S0002-9149(01)01622-8

M3 - Article

C2 - 11448424

AN - SCOPUS:0035879697

VL - 88

SP - 192

EP - 195

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 2

ER -